Developments in utilizing MRI biomarkers in MS

Upcoming MRI biomarkers in multiple sclerosisПодробнее

Implementing MS imaging biomarkers into everyday practiceПодробнее

Key developments in MS: RIS, the MS prodrome, & novel MRI biomarkersПодробнее

Fred Lublin, MD: Biomarkers in MSПодробнее

BTK Inhibitors for MS: Progress in the Development of an Emerging Therapeutic ApproachПодробнее

Role of imaging biomarkers of myelin repair in the development of neuroprotective drugsПодробнее

Brain MRI biomarkers in Multiple SclerosisПодробнее

The development of clinically useful biomarkers in MSПодробнее

Translating MS imaging biomarkers into clinical practiceПодробнее

Developing biomarkers for individual prognostication in MSПодробнее

Emerging MRI Diagnostic Biomarkers for MS: Central Vein Sign & Paramagnetic Rims- Andrew Solomon, MDПодробнее

Shifting Toward Precision Care in MS Using Disease Activity Tests and Serum BiomarkersПодробнее

Developments in biomarkers for MS susceptibility and prodromeПодробнее

Serum proteins associated with glial cell injury, MRI measures & neuropsychological outcomes in MSПодробнее

MS-ReBS: combining visual, radiological, and blood biomarkers for disability prediction in MSПодробнее

Biomarkers for progression and repair in MS - Developing treatments for progressive forms of MSПодробнее

Using biomarkers to tailor treatment options for MSПодробнее

The central vein sign: a novel imaging biomarker for MS diagnosisПодробнее

Enhancing the use of advanced MRI in MS diagnosis and monitoringПодробнее

Imaging biomarkers of RISПодробнее